ReviewCurrent research in pharmacology and drug discovery2021

The development of biologics to target SARS-CoV2: Treatment potential of antibodies in patient groups with poor immune response.

William Migo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.